SCHEMBL6599324

SCHEMBL6599324

OCc1ccc2ccscc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
CYP2A6 P11509 4/20 0.37
CYP2E1 P05181 2/20 0.37
CYP2B6 P20813 2/20 0.37
CHEK1 O14757 2/20 0.36
KCNH2 Q12809 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
HTR1D P28221 1/20 0.34
HTR2B P41595 1/20 0.34
HTR3A P46098 1/20 0.34
HTR5A P47898 1/20 0.34
FYN P06241 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
ERN1 O75460 1/20 0.33
PTPRC P08575 1/20 0.33
CHEK2 O96017 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598549 0.85 MEN1 (0.39) ESR1ESR2CYP2A6CYP2E1CYP2B6
SCHEMBL8058493 0.81 CYP2A6 (0.35) ESR1ESR2CYP2A6CYP2E1CYP2B6
SCHEMBL477489 0.78 CYP2A6 (0.47) CYP2A6CYP2E1CYP2B6PTPRCMEN1
SCHEMBL2092294 0.75 ESR1 (0.31) ESR1ESR2CYP2A6CYP2E1CYP2B6
SCHEMBL276242 0.73 ESR1 (0.50) ESR1ESR2CYP2A6CYP2E1CYP2B6
SCHEMBL5580228 0.73 KMT2A (0.41) CHEK2MEN1KMT2A
SCHEMBL5543516 0.72 ERN1 (0.34) ESR1ESR2ERN1PTPRC
SCHEMBL5324715 0.70 SLC1A3 (0.40) CHEK2
SCHEMBL2096734 0.70 CYP2A6 (0.33) CYP2A6FYN
SCHEMBL5105991 0.70 CYP2A6 (0.52) ESR1ESR2CYP2A6CYP2E1CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed